The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation
Open accessAbstract
Several cues for cell proliferation, migration, and survival are transmitted through lipid rafts, membrane microdomains enriched in sphingolipids and cholesterol. Cells obtain cholesterol from the circulation but can also synthesize cholesterol de novo through the mevalonate/isoprenoid pathway. This pathway, however, has several branches and also produces non-sterol isoprenoids. Squalene synthase (SQS) is the enzyme that determines the switch toward sterol biosynthesis. Here we demonstrate that in prostate cancer cells SQS expression is enhanced by androgens, channeling intermediates of the mevalonate/isoprenoid pathway toward cholesterol synthesis. Interestingly, the resulting increase in de novo synthesis of cholesterol mainly affects the cholesterol content of lipid rafts, while leaving non-raft cholesterol levels unaffected. Conversely, RNA interference-mediated SQS inhibition results in a decrease of raft-associated cholesterol. These data show that SQS activity and de novo cholesterol synthesis are determinants of membrane microdomain-associated cholesterol in cancer cells. Remarkably, SQS knock down also attenuates proliferation and induces death of prostate cancer cells. Similar effects are observed when cancer cells are treated with the chemical SQS inhibitor zaragozic acid A. Importantly, although the anti-tumor effect of statins has previously been attributed to inhibition of protein isoprenylation, the present study shows that specific inhibition of the cholesterol biosynthesis branch of the mevalonate/isoprenoid pathway also induces cancer cell death. These findings significantly underscore the importance of de novo cholesterol synthesis for cancer cell biology and suggest that SQS is a potential novel target for antineoplastic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The encoded protein is the first enzyme in cholesterol biosynthesis and catalyzes the dimerization of two molecules of farnesyl diphosphate via a two-step reaction to form squalene32, which plays an important role in cholesterol biosynthesis33,34.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [32]
In the citing paper
“Farnesyl-diphosphate farnesyltransferase 1 (FDFT1) encodes a membrane-associated enzyme acting at a branch point in the mevalonate pathway.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [32]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Membrane lipid composition and cellular function.
Spector, A. A., & Yorek, M. A. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34276-0 · Cited by 1,495
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Demierre, M., Higgins, P., Gruber, S. B., Hawk, E. T., & Lippman, S. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1751 · Cited by 833
Lipid rafts: contentious only from simplistic standpoints
Hancock, J. F. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1925 · Cited by 788
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567
Li, Y. C., Park, M. J., Ye, S.-K., Kim, C.-W., & Kim, Y.-N. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050959 · Cited by 536
Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
Edwards, P. A., & Ericsson, J. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.157 · Cited by 460
Bergstrom, J. D., Kurtz, M. M., Rew, D. J., Amend, A. M., Karkas, J. D., Bostedor, R., Bansal, V. S., Dufresne, C., VanMiddlesworth, F. L., & Hensens, O. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.80 · Cited by 335
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
Bosland, M. C. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024244 · Cited by 309
Brusselmans, K., De Schrijver, E., Verhoeven, G., & Swinnen, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0571 · Cited by 277
Self-citationCholesterol and prostate cancer
Freeman, M. R., & Solomon, K. R. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10724 · Cited by 272
Schrijver, E. D., Brusselmans, K., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · PubMed · Cited by 269
Self-citationSwinnen, J. V., Ulrix, W., Heyns, W., & Verhoeven, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12975 · Cited by 262
Self-citationSwinnen, J. V., Veldhoven, P. P. V., Timmermans, L., Schrijver, E. D., Brusselmans, K., Vanderhoydonc, F., de Sande, T. V., Heemers, H. V., Heyns, W., & Verhoeven, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00265-1 · Cited by 259
Self-citationAndrogens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen, J. V., Esquenet, M., Goossens, K., Heyns, W., & Verhoeven, G. (1997) · PubMed · Cited by 225
Self-citationXia, Z., Tan, M., Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. Z. (2001) · Leukemia · doi:10.1038/sj.leu.2402196 · Cited by 218
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
Baxter, A., Fitzgerald, B., Hutson, J. L., McCarthy, A. D., Motteram, J., Ross, B. C., Sapra, M., Snowden, M. A., Watson, N. S., & Williams, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49754-8 · Cited by 210
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli, M., Cunningham, G. R., Haidacher, S. J., Padayatty, S. J., Sturgis, L., Kagan, C., & Denner, L. A. (1998) · PubMed · Cited by 210
Brusselmans, K., Schrijver, E. D., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · International Journal of Cancer · doi:10.1002/ijc.11317 · Cited by 205
Self-citationAndrogens, lipogenesis and prostate cancer
Swinnen, J. V., Heemers, H. V., de Sande, T. V., Schrijver, E. D., Brusselmans, K., Heyns, W., & Verhoeven, G. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.013 · Cited by 177
Self-citationHeemers, H. V., Maes, B., Foufelle, F., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0703 · Cited by 172
Self-citationSebti, S. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.005 · Cited by 169
Swinnen, J. V., Veldhoven, P. P. V., Esquenet, M., Heyns, W., & Verhoeven, G. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828509 · Cited by 154
Self-citationThe role of cholesterol in prostate cancer
Hager, M. H., Solomon, K. R., & Freeman, M. R. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232896.66791.62 · Cited by 151
Inhibition of Isoprenoid Biosynthesis Induces Apoptosis in Human Promyelocytic HL-60 Cells
Pérez‐Sala, D., & Mollinedo, F. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1359 · Cited by 144
Androgen Activation of the Sterol Regulatory Element-Binding Protein Pathway: Current Insights
Heemers, H. V., Verhoeven, G., & Swinnen, J. V. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0479 · Cited by 126
Self-citationDenoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 120
Khanzada, U. K., Pardo, O. E., Meier, C., Downward, J., Seckl, M. J., & Arcaro, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209117 · Cited by 109
Molecular Cloning and Functional Analysis of the Promoter of the Human Squalene Synthase Gene
Guan, G., Jiang, G., Koch, R. L., & Shechter, I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21958 · Cited by 108
Self-citationInhibition of pancreatic adenocarcinoma cell growth by lovastatin
Sumi, S., Beauchamp, R. D., Townsend, C. M., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, J., & Thompson, J. C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90032-t · Cited by 107
Guan, G., Dai, P., Osborne, T. F., Kim, J. B., & Shechter, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10295 · Cited by 107
Self-citationVeillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 107
Structure and regulation of mammalian squalene synthase
Tansey, T. R. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00137-2 · Cited by 104
Zhong, W.-B., Wang, C., Chang, T., & Lee, W. (2003) · Endocrinology · doi:10.1210/en.2003-0098 · Cited by 103
Shechter, I., Klinger, E., Rucker, M. L., Engstrom, R. G., Spirito, J. A., Islam, M., Boettcher, B. R., & Weinstein, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42489-1 · Cited by 87
Self-citationUkomadu, C., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307194200 · Cited by 84
Marques, R. B., Erkens‐Schulze, S., de Ridder, C. M., Hermans, K. G., Waltering, K. K., Visakorpi, T., Trapman, J., Romijn, J. C., van Weerden, W. M., & Jenster, G. W. (2005) · International Journal of Cancer · doi:10.1002/ijc.21201 · Cited by 80
Inhibitory effect of statins on the proliferation of human breast cancer cells
Mück, A. O., Seeger, H., & Wallwiener, D. R. (2004) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42695 · Cited by 65
Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes
Bang, B. K., Gniadecki, R., & Gajkowska, B. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00283.x · Cited by 62
Guan, G., Dai, P., & Shechter, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12526 · Cited by 53
Self-citationRegulation of Intracellular Cholesterol Metabolism.
Sato, R., & Takano, T. (1995) · Cell Structure and Function · doi:10.1247/csf.20.421 · Cited by 52
The Mevalonate Synthesis Pathway as a Therapeutic Target in Cancer
Andela, V. B., Pirri, M., Schwarz, E. M., Puzas, E. J., Keefe, R. J. O., Rosenblatt, J. D., & Rosier, R. N. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093846.72468.66 · Cited by 24
Haeffner, E. W., Hoffmann, C. J., Stoehr, M., & Scherf, H. (1984) · PubMed · Cited by 24
Flagged first, then by citations
Research works printed but not linked: 5
- Brown, 1973, Fed. Proc., 32, 2168
- Haeffner, 1984, Cancer Res., 44, 2668
- Marcelli, 1998, Cancer Res., 58, 76
- Swinnen, 1997, Cancer Res., 57, 1086
- De Schrijver, 2003, Cancer Res., 63, 3799
Cited by
Sorted by citations
Lipid metabolic reprogramming in cancer cells
Beloribi‐Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,418
ATP-Citrate Lyase: A Key Player in Cancer Metabolism
Zaidi, N., Swinnen, J. V., & Smans, K. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4112 · Cited by 573
Self-citationLipid metabolism in cancer cells under metabolic stress
Munir, R., Lisec, J., Swinnen, J. V., & Zaidi, N. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0451-4 · Cited by 382
Self-citationMitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
Montero, J., Morales, A., Llacuna, L., Lluis, J. M., Terrones, O., Basáñez, G., Antonsson, B. E., Prìeto, J., García‐Ruiz, C., Colell, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6161 · Cited by 283
Fessler, M. B., & Parks, J. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100253 · Cited by 274
Metadata
- Authors
- Brusselmans, K., Timmermans, L., Van de Sande, T., Van Veldhoven, P. P., Guan, G., Shechter, I., Claessens, F., Verhoeven, G., & Swinnen, J. V.
- Affiliations
- KU Leuven (BE)
- Uniformed Services University of the Health Sciences (US)
- Corresponding author
- Swinnen, Johannes V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 26
- Pages
- 18777-18785
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2136706193
- Cited by
- 116
- References
- 49
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 8
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- squalene synthase, cholesterol biosynthesis, lipid rafts, prostate cancer, androgens, tumor cell proliferation, cancer cell death, statins, zaragozic acid A, sterol biosynthesis
- MeSH terms
- Acetates, Androgens, Carbon Radioisotopes, Cell Division, Cholesterol, Detergents, Enzyme Inhibitors, Humans, Male, Promoter Regions, Genetic, Prostatic Neoplasms, RNA, Messenger, Farnesyl-Diphosphate Farnesyltransferase, Terpenes, Tricarboxylic Acids, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Cell Death, Bridged Bicyclo Compounds, Heterocyclic, Membrane Microdomains, RNA, Small Interfering, Cell Line, Tumor, Sterol Regulatory Element Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review